Foghorn Therapeutics, Inc. (FHTX)
4.37
-0.07
(-1.58%)
USD |
NASDAQ |
Dec 15, 14:58
Foghorn Therapeutics Total Assets (Quarterly): 204.96M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| GT Biopharma, Inc. | 4.321M |
| Recursion Pharmaceuticals, Inc. | 1.400B |
| Erasca, Inc. | 420.40M |
| OmniAb, Inc. | 309.69M |
| CEL-SCI Corp. | 20.34M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 294.62M |
| Shareholders Equity (Quarterly) | -89.66M |
| Debt to Equity Ratio | -0.2513 |
| Current Ratio | 2.164 |
| Net Debt Paydown Yield | 1.33% |